We would like to inform you about the forthcoming funding opportunities in the field of diabetes of:

Therapeutic development and clinical testing of immune therapies for Type 1 Diabetes: late stage preclinical development of promising candidate therapies and clinical studies that utilize novel approaches for testing single therapies or combinations that allow rapid evaluation of their potential will be funded. Preference given to collaborations between academic groups and commercial organizations.

Budget: depends on the scope and overall objectives of maximally 3 years long project.

Submission of template for Expression of Interest is by 5th of August 2019. Full proposal deadline is 31st of October 2019.